As of 2025-07-05, the Relative Valuation of Guardant Health Inc (GH) is (88.52) USD. This relative valuation is based on P/E multiples. With the latest stock price at 50.50 USD, the upside of Guardant Health Inc based on Relative Valuation is -275.3%.
The range of the Relative Valuation is (93.71) - (73.11) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.8x - 37.3x | 32.0x |
| Forward P/E multiples | 19.7x - 21.7x | 20.5x |
| Fair Price | (93.71) - (73.11) | (88.52) |
| Upside | -285.6% - -244.8% | -275.3% |
| Date | P/E |
| 2025-07-03 | -15.00 |
| 2025-07-02 | -14.91 |
| 2025-07-01 | -15.07 |
| 2025-06-30 | -15.46 |
| 2025-06-27 | -15.11 |
| 2025-06-26 | -14.86 |
| 2025-06-25 | -14.83 |
| 2025-06-24 | -14.85 |
| 2025-06-23 | -14.42 |
| 2025-06-20 | -14.60 |
| 2025-06-18 | -15.02 |
| 2025-06-17 | -14.72 |
| 2025-06-16 | -14.65 |
| 2025-06-13 | -14.64 |
| 2025-06-12 | -14.56 |
| 2025-06-11 | -14.57 |
| 2025-06-10 | -14.88 |
| 2025-06-09 | -14.72 |
| 2025-06-06 | -14.28 |
| 2025-06-05 | -14.38 |
| 2025-06-04 | -14.19 |
| 2025-06-03 | -13.60 |
| 2025-06-02 | -12.51 |
| 2025-05-30 | -12.07 |
| 2025-05-29 | -11.45 |
| 2025-05-28 | -11.35 |
| 2025-05-27 | -11.64 |
| 2025-05-23 | -11.29 |
| 2025-05-22 | -11.01 |
| 2025-05-21 | -11.02 |
| 2025-05-20 | -11.88 |
| 2025-05-19 | -11.96 |
| 2025-05-16 | -12.08 |
| 2025-05-15 | -12.02 |
| 2025-05-14 | -12.10 |
| 2025-05-13 | -12.29 |
| 2025-05-12 | -12.38 |
| 2025-05-09 | -12.39 |
| 2025-05-08 | -12.38 |
| 2025-05-07 | -11.81 |
| 2025-05-06 | -12.46 |
| 2025-05-05 | -13.09 |
| 2025-05-02 | -13.92 |
| 2025-05-01 | -14.52 |
| 2025-04-30 | -14.03 |
| 2025-04-29 | -14.72 |
| 2025-04-28 | -14.26 |
| 2025-04-25 | -14.35 |
| 2025-04-24 | -14.09 |
| 2025-04-23 | -13.56 |